Rusnano Of Russia To Invest $40.5 Million In Pharma Facility
This article was originally published in PharmAsia News
Russia’s Rusnano, an investor in nanotechnology, said it would put $40.5 million into a Kirov pharmaceutical facility dedicated to producing nano-carriers.
You may also be interested in...
Firm supplying all-in-one multivitamin blends rather than packs of multiple pills has four-member advisory board including digital marketing and consumer product marketing specialists and a health care strategist.
UK-headquartered company gets further backing from Novo Ventures and other investors convinced of the potential of NLRP3 inhibitors.
Mylan and Pfizer’s Upjohn have revealed a key date for their merger to create Viatris, after the deal set for midway through the year was pushed back recently due to the coronavirus pandemic.